NiraWave™ nano 780

Optical angiography agent

Order no:

NiraWave™ nano 780 optical imaging agent (1 x 5 injections): 130 - 095 - 695
NiraWave™ nano 780 optical imaging agent (5 x 5 injections): 130 - 095 - 693

price per item:
€2,315.00
Excluding VAT and shipping costs

NiraWave nano 780 is a nanoparticulate optical imaging agent for the visualization of vascular fine structure as well as angiogenic processes in tumors and inflammation. It provides a broad excitation range, a high quantum yield and best possible tissue penetration due to fluorescence in the near-infrared range.

NiraWave nano 780, the nanoparticle optical imaging agent:

  • Exhibits a high Stokes-shift and high resistance towards bleaching
  • Is optimized for an extended circulation time
  • Enables a wide imaging time window
  • Accumulates in the liver and spleen
  • NiraWave nano 780 is Viscover's leading agent for optical angiography

Apply NiraWave nano 780 to:

  • Visualize the vascular fine structure
  • Study angiogenesis in tumors and inflammation
Physico-chemical properties and structure
Emission wavelength:

780 nm

Excitation wavelength:

below 740 nm

Schematic diagram of a NiraWave nano 780 nanoparticle



Absorption and emission spectra of
NiraWave nano 780

NiraWave™ nano 780 nanoparticle optical angiography
Optical angiography in mouse injected with NiraWave nano 780. The fine structure of blood vessels is clearly visible, for example, in the hind limbs.
Color-coded image of the same animal showing a vascularized tumor in the hind limb.

Left:Top: Optical angiography in mouse injected with NiraWave nano 780. The fine structure of blood vessels is clearly visible, for example, in the hind limbs.

Right:Bottom: Color-coded image of the same animal showing a vascularized tumor in the hind limb.

Selected references
  1. Ballou, B. et al. (2004) Noninvasive imaging of quantum dots in mice. Bioconjugate Chem. 15:79-86.
  2. Gao, X. et al. (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol.
    22(8): 969-976.
  3. So, M.K. et al. (2006) Self-illuminating quantum dot conjugates for in vivo imaging. Nat. Biotechnol. 24(3): 339-343.
  4. Kuka, J. et al. (2015) Dual Modality Fluorescence and Computed Tomography System for Small Animal In Vivo Imaging. ICNP, Riga, Latvia, p31.
Further information